首页|双参数磁共振在血精诊治中的应用价值

双参数磁共振在血精诊治中的应用价值

扫码查看
目的 探讨双参数磁共振(bpMRI)检查在血精病因判定和治疗策略选择中的应用价值.方法 回顾性分析2019年1月至2023年1月南京医科大学第一附属医院收治的182例血精患者(血精组)的病例资料,以同期51例无泌尿系疾病患者作为对照组.血精组和对照组的年龄[40(33,50)岁与 39(31,53)岁,Z=-0.77,P=0.43]、体质量指数[23.9(22.0,25.7)kg/m2与 24.5(22.3,26.1)kg/m2,Z=-0.50,P=0.62]、吸烟率[24.7%(45/182)与 27.5%(14/51),x2=0.16,P=0.69]、饮酒率[29.1%(53/182)与 29.4%(15/51),x2=0.002,P=0.97]、高血压病患病率[20.9%(38/182)与17.6%(9/51),x2=0.26,P=0.61]差异均无统计学意义;前列腺特异性抗原[2.82(2.08,3.68)ng/ml 与 1.59(0.88,2.28)ng/ml,Z=6.08,P=0.03]差异有统计学意义.对照组和血精组均行bpMRI检查,比较两组bpMRI的影像特点和相关参数.血精组中位患病时间为10(5,15)个月.血精组精液质量分析结果显示,红细胞计数17(10,23)个/HP;尿常规检查提示感染59例(32.4%),血常规检查提示感染15例(8.2%),凝血功能检查异常19例(10.4%).血精组按病因分为5类:感染与炎症105例,梗阻42例,肿瘤19例,全身系统疾病8例,医源性因素及外伤8例.根据病因选择治疗方式:①感染与炎症、全身系统疾病、医源性因素及外伤者去除病因、观察等待;②复发的全身系统疾病、感染与炎症者针对病因用药,采用非甾体抗炎药、α受体阻滞剂等,伴有感染者口服抗生素1~2周;③梗阻、肿瘤者行精囊镜手术、根治性前列腺切除术.治疗后随访12个月评估疗效:治愈为血精症状消失,未复发;显效为症状明显缓解,无肉眼血精,复查精液质量分析提示红细胞明显好转,临床症状和精液检查结果未加重;未愈为肉眼血精持续存在,复查精液质量分析提示红细胞较治疗前无改变;复发为临床症状好转后又出现明显肉眼血精,复查精液质量分析示红细胞计数>5个/HP.结果 血精组和对照组的前列腺影像报告和数据系统(PI-RADS)评分≥3分分别为53例(29.1%)和7例(13.7%),差异有统计学意义(x2=4.94,P=0.03).血精组和对照组的左侧精囊长度[29.9(25.9,33.4)mm 与 23.0(21.2,25.4)mm,Z=7.30,P<0.01]、左侧精囊宽度[20.4(17.8,23.5)mm 与 17.2(15.1,18.5)mm,Z=5.85,P<0.01]、右侧精囊长度[28.9(24.8,32.4)mm 与 23.4(21.5,28.1)mm,Z=4.68,P<0.01]、右侧精囊宽度[19.8(17.7,23.1)mm 与 17.2(15.1,18.6)mm,Z=5.45,P<0.01]比较差异均有统计学意义.血精组治疗后12个月随访,152例(83.5%)治愈、21例(11.5%)显效、4例(2.2%)未愈、5例(2.7%)复发.结论 bpMRI检查可以明确血精病变部位、出血时间,根据bpMRI检查结果判定病因并选择治疗策略是可靠、方便和有效.
The comprehensive analysis of bi-parametric magnetic resonance imaging in the diagnosis and treatment of hematospermia
Objective To investigate the value of bi-parameter magnetic resonance imaging(bpMRI)in diagnosis and treatment of hematospermia.Methods The clinical data and bpMRI of 182 patients with hematospermia(hematospermia group)and 51 patients without urinary system diseases(control group)were retrospectively analyzed.Both the control group and the hematospermia group underwent semen quality analysis,blood routine,urine routine,coagulation function,serum PSA test,and bpMRI examination before treatment.There were no significant differences in age[40(33,50)years vs.39(31,53)years,Z=-0.77,P=0.43],body mass index[23.9(22.0,25.7)kg/m2 vs.24.5(22.3,26.1)kg/m2,Z=-0.50,P=0.62],smoking rate[24.7%(45/182)vs.27.5%(14/51),x2=0.16,P=0.69],alcohol consumption rate[29.1%(53/182)vs.29.4%(15/51),x2=0.002,P=0.97],and comorbid hypertension[20.9%(38/182)vs.17.6%(9/51),x2=0.26,P=0.61]between the hematospermia group and the control group.There was a statistically significant difference in PSA levels between the hematospermia group and the control group[2.82(2.08,3.68)ng/ml vs 1.59(0.88,2.28)ng/ml,Z=6.08,P=0.03].The median duration of illness in the hematospermia group was 10(5,15)months,the median number of red blood cells reported in semen analysis was 17(10,23)/HP,59(32.4%)cases had infections in urine routine results,15(8.2%)cases had infections in blood routine results,and 19(10.4%)cases had coagulation abnormalities.Hematospermia patients can be divided into five categories based on their causes:105 cases of infection and inflammation,42 cases of obstruction,19 cases of tumors,8 cases of systemic diseases,and 8 cases of iatrogenic factors and trauma.The treatment option was based on etiology:①Infections,Inflammation,Systemic Diseases,Iatrogenic Factors,and Trauma:Remove the underlying cause and observe or watchful waiting.②Recurrence of Systemic Diseases,Infections,and Inflammation:Treat the underlying cause with appropriate medication,including nonsteroidal anti-inflammatory drugs(NSAIDs),α-receptor blockers,etc.If there is an infection,administer oral antibiotics for 1-2 weeks.③Obstruction and Tumors:Perform seminal vesiculoscopy surgery or radical prostatectomy.The efficacy evaluation was porfeomed after 12 months of treatment.Cure:Hematospermia symptoms disappear,with no recurrence.Effective:Symptoms significantly improve,no visible hematospermia,semen analysis shows marked improvement in red blood cells,and neither clinical symptoms nor semen analysis worsen.Not Cured:Visible hematospermia persists,and semen analysis shows no change in red blood cells compared to before treatment.Recurrence:Clinical symptoms improve but significant visible hematospermia reappears,and semen analysis shows red blood cell count>5/HP.Results The proportion of patients with PI-RADS scores ≥ 3 in the hematospermia group was higher than that in the control group[29.1%(53/182)vs.13.7%(7/51),x2=4.94,P=0.03],and the difference was statistically significant.Comparing the imaging characteristics and related parameters of two groups of bpMRI,the results showed that the length and width of the left and right seminal vesicles in the hematospermia group were greater than those in the control group.The length of the left seminal vesicle was[29.9(25.9,33.4)mm vs.23.0(21.2,25.4)mm,Z=7.30,P<0.01],the width of the left seminal vesicle was[20.4(17.8,23.5)mm vs.17.2(15.1,18.5)mm,Z=5.85,P<0.01],the length of the right seminal vesicle was[28.9(24.8,32.4)mm vs.23.4(21.5,28.1)mm,Z=4.68,P<0.01],and the width of the right seminal vesicle was[19.8(17.7,23.1)mm vs.17.2(15.1,18.6)mm,Z=5.45,P<0.01].The differences were statistically significant.After 12 months of follow-up,152(83.5%)cases were cured,21(11.5%)cases were defined as effective,4(2.2%)cases were not cured,and 5(2.7%)cases had recurrence.Conclusions The bpMRI examination can clearly identify the location of the hematospermia lesion and the timing of the bleeding.Based on the results of bpMRI,determining the cause and selecting the appropriate treatment strategy is reliable,convenient,and effective.

HemospermiaSeminal vesiculitisMagnetic resonance imagingDiagnose

王亚民、史嵘杰、董来、赵睿哲、王尚乾、成功、华立新

展开 >

南京医科大学第一附属医院泌尿外科,南京 210029

血精 精囊腺炎 磁共振成像 诊断

2024

中华泌尿外科杂志
中华医学会

中华泌尿外科杂志

CSTPCD北大核心
影响因子:1.628
ISSN:1000-6702
年,卷(期):2024.45(12)